{"type":"trials","record":{"id":40120,"source_id":"clinicaltrials-gov","external_id":"NCT03402958","title":"General Practitioner's Place in the Treatment of Fracture Osteoporosis in the Elderly","brief_summary":"Osteoporosis is a major public health problem. Its screening and its treatment remain largely insufficient while therapies have demonstrated their effectiveness. In the event of a severe fracture, the update of the 2016/2017 recommendations, prepared by the Research and Information Group on Osteoporosis and the French Rheumatology Society, concerning osteoporosis recommends a specific treatment with bisphosphonates as first-line treatment, without bone densitometry, regardless of age. The frequency of prescribing anti-osteoporotic treatment as an outpatient after a fracture of the upper extremity of the femur is very low (2% to 21% according to the studies). The main factors associated with non-prescription found are co-morbidities (charlson score\\> 6), dementia, obesity (BMI\\> 30), chronic alcoholism, male sex, polypharmacy\\> 4, age. Conversely, the factors associated with prescribing are recurrent falls (\\> 2 / year), a history of osteoporotic fracture, an Iso Resource Group\\> 3, female sex, and corticosteroid therapy.","overall_status":"Completed","phases":[],"study_type":"OBSERVATIONAL","sponsor":"Rennes University Hospital","enrollment":160,"countries":["France"],"start_date":"2018-03-28","completion_date":"2018-03-28","last_update_date":"2018-09-21","source_url":"https://clinicaltrials.gov/study/NCT03402958","editorial_summary":"A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.","first_seen_at":"2026-09-25T01:25:22.160691+00:00","last_seen_at":"2026-09-25T06:20:19.667+00:00","metadata":{"sex":"ALL","acronym":"GEOFRAGE","age_range":"75 Years","comparator":null,"organization":"Rennes University Hospital","interventions":[],"registry_source":"ClinicalTrials.gov","outcome_measures":["Frequency of prescription of anti-osteoporosis treatments. — 6 months after surgical management for fracture of the upp…","Factors associated with the sub-prescription. — Through study completion, an average of 4 months"],"design_description":null,"source_has_results":false},"controlled_terms":["Osteoporosis"],"relevance_confidence":100,"source_quality_score":100,"freshness_score":50,"publication_state":"published","match_explanation":"Title contains controlled term: osteoporosis.","quality_checked_at":"2026-09-25T06:20:27.00315+00:00","duplicate_cluster_key":"id:nct03402958","duplicate_of_id":null,"evidence_snapshot":{"status":"structured","version":1,"duration":"2018-03-28 to 2018-03-28","comparator":null,"confidence":"structured-source","population":"ALL · 75 Years","provenance":{"duration":"start_date and completion_date","comparator":"registry arm fields","population":"registry eligibility fields","intervention":"registry intervention fields","participants":"enrollment","study_design":"study_type and registry design fields","evidence_stage":"phases","reported_outcome":"not available","outcomes_measured":"registry outcome-measure fields"},"generated_at":"2026-09-25T06:20:19.753Z","intervention":[],"participants":160,"study_design":"OBSERVATIONAL","subject_scope":"Human clinical study registration","evidence_stage":"Phase not reported","safety_context":"Eligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians.","source_support":"Structured registry protocol metadata; no finding-level conclusion is generated.","main_limitation":"This is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.","reported_outcome":null,"outcomes_measured":["Frequency of prescription of anti-osteoporosis treatments. — 6 months after surgical management for fracture of the upp…","Factors associated with the sub-prescription. — Through study completion, an average of 4 months"],"regulatory_context":"Trial registration is not regulatory approval and does not establish that an intervention is available."},"clinical_trial_topics":[{"topic_slug":"bone-aging","is_published":true,"match_reasons":["Title contains controlled term: osteoporosis.","Abstract contains controlled term: osteoporosis.","Source terminology contains: osteoporosis.","Title supplies longevity context: elderly.","Study type is explicitly identified as OBSERVATIONAL."],"matched_fields":["title","abstract","controlled terminology","title context","study type"],"relevance_score":100,"intelligence_topics":{"name":"Bone ageing","slug":"bone-aging"}}],"content_sources":{"name":"ClinicalTrials.gov","homepage_url":"https://clinicaltrials.gov/"}},"canonical_url":"https://www.immortal.life/trials/40120","automation_disclosure":"Generated automatically from cited source metadata. No scientist, clinician, researcher, editor, or human reviewer evaluates this publication before release."}